標(biāo)題: Titlebook: Cardiovascular Genetics and Genomics; Principles and Clini Dhavendra Kumar,Perry Elliott Book 2018 Springer International Publishing AG 201 [打印本頁] 作者: Myelopathy 時(shí)間: 2025-3-21 17:56
書目名稱Cardiovascular Genetics and Genomics影響因子(影響力)
書目名稱Cardiovascular Genetics and Genomics影響因子(影響力)學(xué)科排名
書目名稱Cardiovascular Genetics and Genomics網(wǎng)絡(luò)公開度
書目名稱Cardiovascular Genetics and Genomics網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cardiovascular Genetics and Genomics被引頻次
書目名稱Cardiovascular Genetics and Genomics被引頻次學(xué)科排名
書目名稱Cardiovascular Genetics and Genomics年度引用
書目名稱Cardiovascular Genetics and Genomics年度引用學(xué)科排名
書目名稱Cardiovascular Genetics and Genomics讀者反饋
書目名稱Cardiovascular Genetics and Genomics讀者反饋學(xué)科排名
作者: sparse 時(shí)間: 2025-3-21 23:27
Spectrum and Classification of Inherited Cardiovascular Disease,logues and others attempt to capture complexity in simple form. So it is with inherited cardiac conditions (ICCs). Early classification systems—which remain useful—were based on anatomical/pathological description. As the genetic mechanisms and genes responsible for ICCs were identified, initial att作者: Terminal 時(shí)間: 2025-3-22 01:06 作者: jumble 時(shí)間: 2025-3-22 06:11 作者: 翅膀拍動(dòng) 時(shí)間: 2025-3-22 12:22
Pharmacogenetics and Pharmacogenomics in Cardiovascular Medicine and Surgery,nosis of cardiovascular conditions. However, there is a noticeable difference in the response of individual patients to a given drug, observed in both intermediate phenotypes (e.g. platelet function tests) and clinical outcomes. The aetiology underlying this drug response interindividual variation i作者: ESPY 時(shí)間: 2025-3-22 16:13 作者: ESPY 時(shí)間: 2025-3-22 20:24 作者: 斜谷 時(shí)間: 2025-3-22 21:17
Mitochondrial Cardiovascular Diseases,solation or within the context of a multi-system mitochondrial encephalomyopathy. Hypertrophic cardiomyopathy and conduction defects are common, but other cardiac manifestations have been described. A systematic approach to the biochemical and/or genetic evaluation of these patients will usually ide作者: Culmination 時(shí)間: 2025-3-23 05:09
Inherited Cardiac Muscle Disorders: Hypertrophic and Restrictive Cardiomyopathies,ea, palpitations, syncope and with progressive heart failure or sudden cardiac death. Genetic mutations are the commonest cause of these disorders; having implications for both the affected proband and their extended family. Early identification of the disease process can allow institution of treatm作者: Instrumental 時(shí)間: 2025-3-23 08:30
Inherited Cardiac Muscle Disease: Dilated Cardiomyopathy,he left or both ventricles”. It represents the end-phenotype of heart muscle damage induced by different genetic (>100 known disease genes) and non-genetic causes (inflammatory, toxic, and immune-mediated). In familial genetic DCM, the most common inheritance is autosomal dominant irrespective of th作者: FAWN 時(shí)間: 2025-3-23 13:02
Inherited Cardiac Muscle Disorders: Arrhythmogenic Right Ventricular Cardiomyopathy,or cardiac arrest usually in adolescence or young adulthood. AC represents one of the major causes of sudden death in the young and athletes. The estimated prevalence of AC in the general population ranges from 1:2000 to 1:5000. AC affects more frequently males than females (up to 3:1), despite a si作者: adhesive 時(shí)間: 2025-3-23 17:37
Inherited Cardiac Muscle Disorders: Left Ventricular Noncompaction,y, it is characterized by prominent ventricular trabeculae and deep intertrabecular recesses. It has traditionally been thought to be related to intrauterine arrest of myocardial development. While it is classified as a primary cardiomyopathy of genetic origin by the American Heart Association, the 作者: 啞劇 時(shí)間: 2025-3-23 20:04 作者: Aerate 時(shí)間: 2025-3-24 00:55
Inherited Arrhythmias: Brugada Syndrome and Early Repolarisation Syndrome,with malignant arrhythmias and sudden death in otherwise healthy young adults and even children. We discuss their history, clinical perspectives (including patient characteristics and epidemiology), the pathway to the diagnosis, pathophysiological mechanisms (including genetic associations) and revi作者: 生意行為 時(shí)間: 2025-3-24 03:53
Inherited Conduction Disease and Atrial Fibrillation,sinus node, atrial myocytes or conduction system can result in sinus bradycardia, atrial fibrillation (AF) or premature atrioventicular block..This chapter discusses the key molecular mechanisms determining the development of AF & conduction disorders. Both may exist as a monogenic disease, and rese作者: ferment 時(shí)間: 2025-3-24 07:21
Cardiovascular Manifestations in Duchenne/Becker Muscular Dystrophy and Other Primary Myopathies,asis, and as such this is the initial focus from a clinical perspective. Over the past decades, improvements in physical and respiratory therapy, coupled with advances in technology, have substantially improved quality of life for this patient group. Improvements in computer technology such as voice作者: tendinitis 時(shí)間: 2025-3-24 13:16 作者: 宣傳 時(shí)間: 2025-3-24 18:31 作者: HAWK 時(shí)間: 2025-3-24 19:06 作者: 針葉 時(shí)間: 2025-3-25 02:55 作者: MURKY 時(shí)間: 2025-3-25 06:52 作者: Metamorphosis 時(shí)間: 2025-3-25 10:12
24-96 - 24-222: C6H8ClN3 - C7ClF5O,dical, psychological, familial and reproductive implications of the genetic contribution to specific health conditions”. Genetic counselling can be applied within different medical settings and can therefore be tailored to provide specific information relevant to the particular condition present wit作者: 破裂 時(shí)間: 2025-3-25 14:52 作者: Osteoporosis 時(shí)間: 2025-3-25 17:47
26-82 - 26-162: C7H12Cl2O - C8H4ClO5ReS,nosis of cardiovascular conditions. However, there is a noticeable difference in the response of individual patients to a given drug, observed in both intermediate phenotypes (e.g. platelet function tests) and clinical outcomes. The aetiology underlying this drug response interindividual variation i作者: paragon 時(shí)間: 2025-3-25 21:38 作者: TAP 時(shí)間: 2025-3-26 01:34 作者: CRAMP 時(shí)間: 2025-3-26 05:57 作者: 調(diào)情 時(shí)間: 2025-3-26 08:52
24-1 - 24-95: C6H5Cl4N - C6H8ClNO2,ea, palpitations, syncope and with progressive heart failure or sudden cardiac death. Genetic mutations are the commonest cause of these disorders; having implications for both the affected proband and their extended family. Early identification of the disease process can allow institution of treatm作者: Pageant 時(shí)間: 2025-3-26 12:46
23-116 - 23-221: C6H4Cl2N2O2S - C6H5Cl3Sn,he left or both ventricles”. It represents the end-phenotype of heart muscle damage induced by different genetic (>100 known disease genes) and non-genetic causes (inflammatory, toxic, and immune-mediated). In familial genetic DCM, the most common inheritance is autosomal dominant irrespective of th作者: 松馳 時(shí)間: 2025-3-26 17:38 作者: 癡呆 時(shí)間: 2025-3-26 23:15
26-163 - 26-222: C8H4Cl2N2 - C8H6Cl2O,y, it is characterized by prominent ventricular trabeculae and deep intertrabecular recesses. It has traditionally been thought to be related to intrauterine arrest of myocardial development. While it is classified as a primary cardiomyopathy of genetic origin by the American Heart Association, the 作者: condemn 時(shí)間: 2025-3-27 04:54
24-96 - 24-222: C6H8ClN3 - C7ClF5O,al activity of the heart. These mutations predispose affected individuals to the development of life-threatening ventricular arrhythmias (polymorphic ventricular tachycardia/ventricular fibrillation) either by altering the fine-tuned equilibrium of ionic currents in the cardiac action potential, or 作者: Adulate 時(shí)間: 2025-3-27 09:02 作者: Bricklayer 時(shí)間: 2025-3-27 12:50
1.3 Arrangement of tables and data,sinus node, atrial myocytes or conduction system can result in sinus bradycardia, atrial fibrillation (AF) or premature atrioventicular block..This chapter discusses the key molecular mechanisms determining the development of AF & conduction disorders. Both may exist as a monogenic disease, and rese作者: Compass 時(shí)間: 2025-3-27 17:37
24-1 - 24-95: C6H5Cl4N - C6H8ClNO2,asis, and as such this is the initial focus from a clinical perspective. Over the past decades, improvements in physical and respiratory therapy, coupled with advances in technology, have substantially improved quality of life for this patient group. Improvements in computer technology such as voice作者: GRUEL 時(shí)間: 2025-3-27 20:17 作者: Felicitous 時(shí)間: 2025-3-27 22:07
1.3 Arrangement of tables and data,sorders and predominantly affect the conduction system of the heart. Tachy and bradyarrhythmias are the predominant cardiac manifestation and are associated with up to 30% of all cause mortality in DM. Routine cardiac screening is recommended in all patients with a minimum of a yearly ECG, ECHO and 作者: Defense 時(shí)間: 2025-3-28 04:23 作者: essential-fats 時(shí)間: 2025-3-28 07:18 作者: fetter 時(shí)間: 2025-3-28 12:08
Dhavendra Kumar,Perry ElliottProvides a concise, clinically oriented resource, targeted at broad range of clinicians managing patients and families with a wide range of heterogeneous inherited cardiovascular conditions.Written by作者: Armory 時(shí)間: 2025-3-28 14:57 作者: 氣候 時(shí)間: 2025-3-28 20:32
https://doi.org/10.1007/978-3-319-66114-8Adult congenital heart disease; Cardiac Genomics; Familial cardiomyopathies; Gene sequencing; Inherited 作者: 植物茂盛 時(shí)間: 2025-3-29 00:17
978-3-319-88179-9Springer International Publishing AG 2018作者: 講個(gè)故事逗他 時(shí)間: 2025-3-29 07:09
25-1 - 25-95: C7Cl2F4N2 - C7H5ClF3N,fect the individual at any stage from fetal to adult life. It also encompasses abnormalities encountered in postnatal adaptation, such as persistence of the ductus arteriosus. Cardiovascular abnormalities, as a group, are the most common cause of congenital anomaly and account for around 1% of live births.作者: jealousy 時(shí)間: 2025-3-29 10:52 作者: 舔食 時(shí)間: 2025-3-29 14:11 作者: 爭(zhēng)議的蘋果 時(shí)間: 2025-3-29 18:07
24-96 - 24-222: C6H8ClN3 - C7ClF5O, therapy, this heterogeneity remains challenging to classify and, ultimately, a combined approach is necessary. As genomic medicine progresses and we enter an era of personalised medicine, our ability to develop an organic classification system able to deal with complexity will be key.作者: –scent 時(shí)間: 2025-3-29 21:24
24-1 - 24-95: C6H5Cl4N - C6H8ClNO2, help identify other individuals at risk of developing the disease phenotype. The following chapter provides insight into the genetic aetiology underlying these diverse disease processes and the clinical management of these inherited cardiomyopathies.作者: 平項(xiàng)山 時(shí)間: 2025-3-30 03:58
23-116 - 23-221: C6H4Cl2N2O2S - C6H5Cl3Sn, clinical history and pathology investigations. Genetic tests in probands and cascade family screening in clinically phenotyped families provide the basis for segregation studies that are major contributors to the assignment of a causative role of mutations in families.作者: 思想流動(dòng) 時(shí)間: 2025-3-30 06:35
26-163 - 26-222: C8H4Cl2N2 - C8H6Cl2O,ugh it is often associated with other congenital cardiac anomalies it can also be seen in association with dilated, hypertrophic and restrictive cardiomyopathies and in the absence of any cardiac defects.作者: Fresco 時(shí)間: 2025-3-30 11:07
24-96 - 24-222: C6H8ClN3 - C7ClF5O,bers may be predisposed to the same potentially lethal arrhythmias. If a timely diagnosis is reached, however, simple and efficacious preventive measures may be applied in most cases. Genetic information plays a pivotal role for the diagnosis of inherited arrhythmias and may help in the clinical management of patients and their relatives.作者: septicemia 時(shí)間: 2025-3-30 14:47 作者: Allowance 時(shí)間: 2025-3-30 18:19 作者: maroon 時(shí)間: 2025-3-30 21:07
Spectrum and Classification of Inherited Cardiovascular Disease, therapy, this heterogeneity remains challenging to classify and, ultimately, a combined approach is necessary. As genomic medicine progresses and we enter an era of personalised medicine, our ability to develop an organic classification system able to deal with complexity will be key.作者: 凈禮 時(shí)間: 2025-3-31 04:35
Inherited Cardiac Muscle Disorders: Hypertrophic and Restrictive Cardiomyopathies, help identify other individuals at risk of developing the disease phenotype. The following chapter provides insight into the genetic aetiology underlying these diverse disease processes and the clinical management of these inherited cardiomyopathies.作者: 誰在削木頭 時(shí)間: 2025-3-31 07:01 作者: 動(dòng)機(jī) 時(shí)間: 2025-3-31 11:09 作者: 大罵 時(shí)間: 2025-3-31 17:20 作者: 有助于 時(shí)間: 2025-3-31 18:08 作者: 旋轉(zhuǎn)一周 時(shí)間: 2025-3-31 23:09
Book 2018ular genetics and genomics. Therefore this will be of key importance to all professionals working in the discipline, from clinicians and trainees in cardiology, cardiac surgery, electrophysiology, immunology through geneticists, nursing staff and those involved in precision medicine..作者: Atrium 時(shí)間: 2025-4-1 04:21
Inherited Cardiovascular Metabolic Disorders,eded to reach the correct diagnosis. Diagnosis is important because many of these disorders (partly) respond to treatments such as dietary modification, co-factor administration, enzyme replacement therapy, or haematopoietic stem cell transplantation.作者: 無可爭(zhēng)辯 時(shí)間: 2025-4-1 09:56 作者: Wernickes-area 時(shí)間: 2025-4-1 13:01
heterogeneous inherited cardiovascular conditions.Written by.This title reflects the exponential growth in the knowledge and information on this subject and defines the extensive clinical translation of cardiovascular genetics and genomics in clinical practice. This concise, clinically oriented text作者: barium-study 時(shí)間: 2025-4-1 17:23 作者: brother 時(shí)間: 2025-4-1 22:01 作者: cringe 時(shí)間: 2025-4-2 02:39 作者: 王得到 時(shí)間: 2025-4-2 04:22 作者: Jingoism 時(shí)間: 2025-4-2 08:34
Mitochondrial Cardiovascular Diseases,ther cardiac manifestations have been described. A systematic approach to the biochemical and/or genetic evaluation of these patients will usually identify the underlying cause, enabling genetic counseling and supportive management of both the cardiac and extra-cardiac features.
